150 related articles for article (PubMed ID: 18502329)
1. Genome-wide studies in thyroid neoplasia.
Giordano TJ
Endocrinol Metab Clin North Am; 2008 Jun; 37(2):311-31, vii-viii. PubMed ID: 18502329
[TBL] [Abstract][Full Text] [Related]
2. Microarray analysis refines classification of non-medullary thyroid tumours of uncertain malignancy.
Fontaine JF; Mirebeau-Prunier D; Franc B; Triau S; Rodien P; Houlgatte R; Malthièry Y; Savagner F
Oncogene; 2008 Apr; 27(15):2228-36. PubMed ID: 17968324
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic dysregulation in thyroid neoplasia.
Kondo T; Asa SL; Ezzat S
Endocrinol Metab Clin North Am; 2008 Jun; 37(2):389-400, ix. PubMed ID: 18502333
[TBL] [Abstract][Full Text] [Related]
4. Thyroid cancer: the impact of emerging technologies on clinical practice guidelines.
Mechanick JI; Carpi A
Biomed Pharmacother; 2008 Oct; 62(8):554-8. PubMed ID: 18752920
[TBL] [Abstract][Full Text] [Related]
5. Can a gene-expression classifier with high negative predictive value solve the indeterminate thyroid fine-needle aspiration dilemma?
Faquin WC
Cancer Cytopathol; 2013 Mar; 121(3):116-9. PubMed ID: 23364882
[TBL] [Abstract][Full Text] [Related]
6. New, clinically relevant molecular characterizations of thyroid cancer.
Davis PJ
Curr Opin Endocrinol Diabetes Obes; 2009 Oct; 16(5):359-60. PubMed ID: 19654539
[No Abstract] [Full Text] [Related]
7. Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers.
Griffith OL; Melck A; Jones SJ; Wiseman SM
J Clin Oncol; 2006 Nov; 24(31):5043-51. PubMed ID: 17075124
[TBL] [Abstract][Full Text] [Related]
8. Recent developments in the clinical application of thyroid cancer biomarkers.
Shibru D; Chung KW; Kebebew E
Curr Opin Oncol; 2008 Jan; 20(1):13-8. PubMed ID: 18043251
[TBL] [Abstract][Full Text] [Related]
9. Thyroid tumor marker genomics and proteomics: diagnostic and clinical implications.
Carpi A; Mechanick JI; Saussez S; Nicolini A
J Cell Physiol; 2010 Sep; 224(3):612-9. PubMed ID: 20578236
[TBL] [Abstract][Full Text] [Related]
10. [Thyroid insular carcinoma].
Franc B; Ledent C; de Saint-Maur PP; Parmentier M
Arch Anat Cytol Pathol; 1998; 46(1-2):63-78. PubMed ID: 9754361
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide gene expression profiles of thyroid carcinoma: Identification of molecular targets for treatment of thyroid carcinoma.
Nikolova DN; Zembutsu H; Sechanov T; Vidinov K; Kee LS; Ivanova R; Becheva E; Kocova M; Toncheva D; Nakamura Y
Oncol Rep; 2008 Jul; 20(1):105-21. PubMed ID: 18575725
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotyping of thyroid tumors identifies molecular markers altered during transformation of differentiated into anaplastic carcinoma.
Wiseman SM; Griffith OL; Gown A; Walker B; Jones SJ
Am J Surg; 2011 May; 201(5):580-6. PubMed ID: 21545903
[TBL] [Abstract][Full Text] [Related]
13. Anaplastic transformation of thyroid cancer: review of clinical, pathologic, and molecular evidence provides new insights into disease biology and future therapy.
Wiseman SM; Loree TR; Rigual NR; Hicks WL; Douglas WG; Anderson GR; Stoler DL
Head Neck; 2003 Aug; 25(8):662-70. PubMed ID: 12884350
[TBL] [Abstract][Full Text] [Related]
14. Thyroid nodules and cancers in children.
Halac I; Zimmerman D
Endocrinol Metab Clin North Am; 2005 Sep; 34(3):725-44, x. PubMed ID: 16085168
[TBL] [Abstract][Full Text] [Related]
15. Analysis of deregulated miRNAs is helpful to distinguish poorly differentiated thyroid carcinoma from papillary thyroid carcinoma.
Schwertheim S; Sheu SY; Worm K; Grabellus F; Schmid KW
Horm Metab Res; 2009 Jun; 41(6):475-81. PubMed ID: 19370508
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling of thyroid tumors--clinical applicability.
Lubitz CC; Fahey TJ
Nat Clin Pract Endocrinol Metab; 2006 Sep; 2(9):472-3. PubMed ID: 16957755
[No Abstract] [Full Text] [Related]
17. [Morphological analysis of genetically damaged thyrocytes in nodular pathology of the thyroid gland].
Pavlov AV; Aleksandrov IuK; Beliakov IE; Korableva TV
Vestn Khir Im I I Grek; 2007; 166(2):58-61. PubMed ID: 17665578
[TBL] [Abstract][Full Text] [Related]
18. Predicting favourable prognosis of urothelial carcinoma: gene expression and genome profiling.
van der Kwast TH; Bapat B
Curr Opin Urol; 2009 Sep; 19(5):516-21. PubMed ID: 19553819
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of molecular markers in follicular cell-derived thyroid cancer.
Pinto AE; Leite V; Soares J
Expert Rev Mol Diagn; 2009 Oct; 9(7):679-94. PubMed ID: 19817553
[TBL] [Abstract][Full Text] [Related]
20. Thyroid nodules and cancers in children.
Josefson J; Zimmerman D
Pediatr Endocrinol Rev; 2008 Sep; 6(1):14-23. PubMed ID: 18806721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
